Ignite Creation Date:
2024-05-06 @ 1:35 PM
Last Modification Date:
2024-10-26 @ 1:16 PM
Study NCT ID:
NCT04065399
Status:
RECRUITING
Last Update Posted:
2024-05-17
First Post:
2019-08-16
Brief Title:
A Study of Revumenib in RR Leukemias Including Those With an MLLKMT2A Gene Rearrangement or NPM1 Mutation
Sponsor:
Syndax Pharmaceuticals
Organization:
Syndax Pharmaceuticals
Organization Data
Organization:
Syndax Pharmaceuticals
Class:
INDUSTRY
Study ID:
SNDX-5613-0700
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Syndax Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None